Back to search

Article

Matrix-targeted Nanoparticles for MMP13 RNA Interference Blocks Post-Traumatic Osteoarthritis

2020-01-31

Abstract excerpt

Osteoarthritis (OA) is a debilitating and prevalent chronic disease, but there are no approved disease modifying OA drugs (DMOADs), only pharmaceuticals for pain management. OA progression, particularly for post-traumatic osteoarthritis (PTOA), is associated with inflammation and enzymatic degradation of the extracellular matrix. In particular, Matrix Metalloproteinase 13 (MMP13) breaks down collagen type 2 (CII),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c9c3ad1-6a90-5c46-8724-fca16feb0f16
DOI
10.1101/2020.01.30.925321
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Matrix-targeted Nanoparticles for MMP13 RNA Interference Blocks Post-Traumatic OsteoarthritisDOI 10.1101/2020.01.30.925321
Select a neighboring publication to make it the new centre.